Biogen (BIIB) Research & Development (2009 - 2026)

Biogen's Research & Development history runs 18 years deep, the most recent figure standing at $539.0 million for Q1 2026.

• In Q1 2026, Research & Development rose 24.16% year-over-year to $539.0 million; the TTM figure through Mar 2026 stood at $1.9 billion (down 4.34% YoY), while the FY2025 annual figure was $1.8 billion, down 10.19% from the prior year.
• Research & Development was $539.0 million for Q1 2026 at Biogen, up from $509.4 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $736.3 million in Q3 2023 to a low of $75.0 million in Q4 2023.
• Historically, Research & Development has averaged $499.7 million across 5 years, with a median of $516.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Research & Development plunged 87.53% in 2023, then jumped 584.4% in 2024.
• A 5-year view of Research & Development shows it stood at $601.6 million in 2022, then slumped by 87.53% to $75.0 million in 2023, then surged by 584.4% to $513.3 million in 2024, then declined by 0.76% to $509.4 million in 2025, then gained by 5.81% to $539.0 million in 2026.
• The last three Research & Development figures came in at $539.0 million (Q1 2026), $509.4 million (Q4 2025), and $436.1 million (Q3 2025), per Business Quant data.